New Polymorphs of Huperzine A: Preparation, Structures, and Physicochemical Properties of Anhydrous Crystal Forms

被引:32
作者
Zhang, Qi [1 ]
Lu, Liye [1 ]
Dai, Wenjuan [1 ]
Mei, Xuefeng [1 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Mat Med, Pharmaceut Analyt & Solid State Chem Res Ctr, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
PHARMACEUTICAL SOLID POLYMORPHISM; SELECTIVE CRYSTALLIZATION; ALZHEIMERS-DISEASE; DRUG APPLICATIONS; TABLETS; SPECTROSCOPY; INSIGHTS; SYSTEM;
D O I
10.1021/cg400313a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Three new polymorphs (forms I, II, and III) of natural cholinesterase inhibitor Huperzine A were discovered through a comprehensive polymorph screening experiment. Their structures were elucidated by single crystal structure analysis and characterized by powder X-ray diffraction, Fourier transform-infrared spectroscopy, and DXR Raman microscope. The physicochemical properties of these new forms were investigated by thermal analysis (TGA and DSC) and dynamic vapor sorption (DVS) isotherms. The powder dissolution rates were compared with the marketed monohydrate form. Thermodynamic stability, phase transformation, E-T diagram, and drugability properties are also discussed in detail.
引用
收藏
页码:2198 / 2207
页数:10
相关论文
共 28 条
[11]   Multiple approaches to pharmaceutical polymorphism investigation-A case study [J].
Li, Haitao ;
Kiang, Y. -H. ;
Jona, Janan .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 38 (05) :426-432
[12]   Huperzine a from Huperzia species -: an ethnopharmacolgical review [J].
Ma, Xiaoqiang ;
Tan, Changheng ;
Zhu, Dayuan ;
Gang, David R. ;
Xiao, Peigen .
JOURNAL OF ETHNOPHARMACOLOGY, 2007, 113 (01) :15-34
[13]   Is there a better source of huperzine A than Huperzia serrata?: Huperzine A content of huperziaceae species in China [J].
Ma, XQ ;
Tan, CH ;
Zhu, DY ;
Gang, DR .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2005, 53 (05) :1393-1398
[14]   The use of high-speed differential scanning calorimetry (Hyper-DSC™) in the study of pharmaceutical polymorphs [J].
McGregor, Caroline ;
Bines, Emma .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 350 (1-2) :48-52
[15]   (6R, 10R, 14E)-6-Amino-12-ethylidene-8-methyl-6,7,10,12-tetrahydro-6,10-methanocycloocta[b]-pyridin-2(1H)-one monohydrate [J].
Meng, Zhao-Ling ;
Sun, Ai-Ling ;
Liu, Ren-Min ;
Wang, Da-Qi .
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2006, 62 :O4911-O4912
[16]   Determination of carbamazepine polymorphic contents in double-layered tablets using transmittance- and reflectance-near-infrared spectroscopy involving chemometrics [J].
Otsuka, Makoto ;
Fukui, Yuya .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2010, 36 (12) :1404-1412
[17]   Evaluation of the compaction of sulfathiazole polymorphs [J].
Picker-Freyer, Katharina Maria ;
Liao, Xiangmin ;
Zhang, Guifang ;
Wiedmann, Timothy Scott .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (08) :2111-2124
[18]   Regulatory considerations of pharmaceutical solid polymorphism in abbreviated new drug applications (ANDAs) [J].
Raw, AS ;
Furness, MS ;
Gill, DS ;
Adams, RC ;
Holcombe, FO ;
Yu, LX .
ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (03) :397-414
[19]   Raman Chemical Mapping of Low-Content Active Pharmaceutical Ingredient Formulations. III. Statistically Optimized Sampling and Detection of Polymorphic Forms in Tablets on Stability [J].
Sasic, Slobodan ;
Mehrens, Shawn .
ANALYTICAL CHEMISTRY, 2012, 84 (02) :1019-1025
[20]   A short history of SHELX [J].
Sheldrick, George M. .
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2008, 64 :112-122